Risk factors for coronary heart disease in connective tissue diseases

Awal Al Husain1, Ian N Bruce

  • 1arc Epidemiology Unit, School of Translational Medicine, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK, The Kellgren Centre for Rheumatology, Central Manchester Foundation Trust, Manchester, UK.

Insights

Patients with connective tissue diseases face higher cardiovascular disease risk due to multifactorial causes including inflammation. Proactive screening for modifiable risk factors is recommended for these patients.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Immunology

Background:

  • Connective tissue diseases like systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are associated with enhanced atherosclerosis and cardiovascular disease (CVD) risk.
  • Traditional CVD risk factors are more prevalent in these patient groups, but do not fully account for the elevated risk.
  • Chronic inflammation and specific autoantibodies may contribute to increased CVD risk, though their roles are debated.

Purpose of the Study:

  • To explore the multifactorial reasons behind accelerated atherosclerosis and CVD risk in patients with specific connective tissue diseases.
  • To evaluate the impact of traditional risk factors, chronic inflammation, autoantibodies, and therapies on CVD risk in these populations.

Main Methods:

  • Review of existing literature on cardiovascular risk in connective tissue diseases.
  • Analysis of the prevalence of traditional risk factors in patient cohorts.
  • Discussion of the potential roles of chronic inflammation, autoantibodies, and therapeutic interventions.

Main Results:

  • Accelerated atherosclerosis and CVD risk are observed in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic vasculitis, and antiphospholipid syndrome.
  • While traditional risk factors are more common, they don't fully explain the enhanced CVD risk.
  • Chronic inflammation and certain autoantibodies are implicated, but their exact contribution requires further research.
  • Therapies present a complex picture: steroids may worsen metabolic risk, while anti-inflammatory treatments might reduce overall CVD risk.

Conclusions:

  • The enhanced cardiovascular risk in connective tissue diseases is multifactorial, involving both traditional and disease-specific factors.
  • Proactive screening for modifiable cardiovascular risk factors is crucial for patients diagnosed with these conditions.
  • Further research is needed to clarify the precise roles of inflammation, autoantibodies, and therapies in modulating cardiovascular risk.

Related Concept Videos

Introduction to Connective Tissues01:11

Introduction to Connective Tissues

Connective tissues are one of the four main tissue types in humans that are extensively present in the body. They are characterized by cells embedded in an extracellular matrix (ECM) composed of a ground substance and three main types of protein fibers— collagen, elastic, and reticular fibers. The ground substance of connective tissues can range from a watery and jelly-like consistency to mineralized and hard. The wide variety of cells in the connective tissues include fibroblasts, osteocytes,...
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...